The Call For Drug-Price Transparency Is Growing Louder — But Will It Matter?


Newly appointed Health and Human Services Secretary Alex Azar has been charged with bringing down drug prices. He’s a fan of demanding transparency from drug companies, but many states have already done that, and the impact on pricing is unclear.March 30, 2018 at 09:30AM

via Forbes Real Time https://ift.tt/2Gl94JP